Practical application of the virtual crossmatch

Pediatric Transplantation

Volumn 11, Issue 6, 2007, Pages 650-654

  Zangwill, Steven ^a   Ellis, Thomas ^a   Stendahl, Gail ^a   Zahn, Amy ^a   Berger, Stuart ^b   Tweddell, James ^a  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

Anti HLA antibody; HLA antigens; Pediatric heart transplant

Indexed keywords

CALCINEURIN INHIBITOR; DACLIZUMAB; IMMUNOGLOBULIN; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THYMOCYTE ANTIBODY;

ANTIBODY SCREENING; ARTICLE; ASSAY; CLINICAL ARTICLE; CYTOTOXICITY TEST; DEATH; DETERIORATION; DRUG DOSE TITRATION; FEMALE; FISHER EXACT TEST; FLOW CYTOMETRY; GRAFT REJECTION; HLA SYSTEM; HUMAN; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIZATION; STUDENT T TEST; SURVIVAL RATE; VIRTUAL CROSSMATCH;

CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 34547404663     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00746.x     Document Type: Article

References (12)

1. Jacobs JP, Quintessenza JA, Boucek RJ, et al. Pediatric cardiac transplantation in children with high panel reactive antibody. Pediatr Card Transplant 2004 : 78 : 1703 1709.
2. Shaddy RE, Fuller TC. The sensitized pediatric heart transplant candidate: Causes, consequences, and treatment options. Pediatr Transplant 2005 : 9 : 208 214.
3. Leech SH, Lopez-Cepero M, Lefor WM, et al. Management of the sensitized cardiac recipient: The use of plasmapheresis and intravenous immunoglobulin. Clin Transplant 2006 : 20 : 476 484.
4. Organ Procurement and Transplantation Network. Health resources and services administration. Department of Health and Human Services, 2006.
5. Lavee J, Kormos RL, Duquesnoy RJ, et al. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant 1991 : 10 : 921 930.
6. Loh E, Bergin JD, Couper GS, Mudge GH. Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation. J Heart Lung Transplant 1994 : 13 : 194 201.
7. Zangwill SD, Ellis TM, Zlotocha J, et al. The virtual crossmatch - A screening tool for sensitized pediatric heart transplant recipients. Pediatr Transplant 2006 : 10 : 1 4.
8. Difilippo S, Girnita A, Webber SA, et al. Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome. Hum Immunol 2005 : 66 : 513 518.
9. Kobashigawa JA, Sabad A, Drinkwater D, et al. Pretransplant panel reactive-antibody screens: Are they truly a marker for poor outcome after cardiac transplantation? Circulation 1996 : 94 : II294 II297.
10. Itescu S, Tung TC, Burke EM, et al. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation 1998 : 98 : 786 793.
11. Pisani BA, Mullen M, Malinowska K, et al. Plasmapheresis with intravenous immunoglobulin G effective in patients with elevated panel reactive antibody prior to cardiac transplantation. J Heart Lung Transplant 1999 : 18 : 701 706.
12. Pescovitz MD. B cells: A rational target in alloantibody-mediated solid organ transplantation rejection. Clin Transplant 2006 : 20 : 48 54.